THRESHOLD PHARMACEUTICALS, INC. SAYS TO CUT ONE THIRD OF JOBS, CFO TO LEAVE

Threshold Pharmaceuticals, Inc., reported financial results for the second quarter ended June 30, 2006, a corporate realignment to focus on programs for multiple potential cancer indications and adoption of a shareholder rights plan.
BioSpace